442 related articles for article (PubMed ID: 10510313)
21. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
[TBL] [Abstract][Full Text] [Related]
22. Quantifying the sequence-dependent species barrier between hamster and mouse prions.
Lee LY; Chen RP
J Am Chem Soc; 2007 Feb; 129(6):1644-52. PubMed ID: 17243682
[TBL] [Abstract][Full Text] [Related]
23. beta-sheet constitution of prion proteins.
Ji HF; Zhang HY
Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
[TBL] [Abstract][Full Text] [Related]
24. The unfolded state of the murine prion protein and properties of single-point mutants related to human prion diseases.
Gerum C; Schlepckow K; Schwalbe H
J Mol Biol; 2010 Aug; 401(1):7-12. PubMed ID: 20541558
[TBL] [Abstract][Full Text] [Related]
25. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
26. Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with beta or alpha features.
Derreumaux P
Biophys J; 2001 Sep; 81(3):1657-65. PubMed ID: 11509378
[TBL] [Abstract][Full Text] [Related]
27. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
Kourie JI
Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
[TBL] [Abstract][Full Text] [Related]
28. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
[TBL] [Abstract][Full Text] [Related]
29. Tuning the conformational properties of the prion peptide.
Ho CC; Lee LY; Huang KT; Lin CC; Ku MY; Yang CC; Chan SI; Hsu RL; Chen RP
Proteins; 2009 Jul; 76(1):213-25. PubMed ID: 19137620
[TBL] [Abstract][Full Text] [Related]
30. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
31. Protein conformation and disease.
Nandi PK
Vet Res; 1996; 27(4-5):373-82. PubMed ID: 8822608
[TBL] [Abstract][Full Text] [Related]
32. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
[TBL] [Abstract][Full Text] [Related]
33. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core.
Wasmer C; Lange A; Van Melckebeke H; Siemer AB; Riek R; Meier BH
Science; 2008 Mar; 319(5869):1523-6. PubMed ID: 18339938
[TBL] [Abstract][Full Text] [Related]
34. Generating recombinant C-terminal prion protein fragments of exact native sequence.
Johanssen VA; Barnham KJ; Masters CL; Hill AF; Collins SJ
Neurochem Int; 2012 Feb; 60(3):318-26. PubMed ID: 22197912
[TBL] [Abstract][Full Text] [Related]
35. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and structural studies of the prion protein polymorphism.
Petchanikow C; Saborio GP; Anderes L; Frossard MJ; Olmedo MI; Soto C
FEBS Lett; 2001 Dec; 509(3):451-6. PubMed ID: 11749972
[TBL] [Abstract][Full Text] [Related]
37. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
[TBL] [Abstract][Full Text] [Related]
38. A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice.
Kaneko K; Ball HL; Wille H; Zhang H; Groth D; Torchia M; Tremblay P; Safar J; Prusiner SB; DeArmond SJ; Baldwin MA; Cohen FE
J Mol Biol; 2000 Jan; 295(4):997-1007. PubMed ID: 10656806
[TBL] [Abstract][Full Text] [Related]
39. Scrapie-infected cells, isolated prions, and recombinant prion protein: a comparative study.
Kneipp J; Miller LM; Spassov S; Sokolowski F; Lasch P; Beekes M; Naumann D
Biopolymers; 2004 May-Jun 5; 74(1-2):163-7. PubMed ID: 15137116
[TBL] [Abstract][Full Text] [Related]
40. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
